NVS240719P120000
- 15.02
- 0.000.00%
Novartis AG Newsroom
UBS Sticks to Their Buy Rating for Novartis AG (NOVN)
Novartis AG (NOVN) Gets a Hold From Citi
Novartis Analyst Ratings
Berenberg Raises Price Target on Novartis to CHF77 From CHF74, Maintains Hold Rating
Novartis Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD)
Vertex Pharma Upgraded at Evercore on Alpine Immune Deal
Analysts Offer Insights on Healthcare Companies: Shop Apotheke Europe NV (GB:0RJT), Stryker (SYK) and Novartis AG (Six Swiss: CH:NOVN)
Novartis Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Novartis Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Novartis Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Wedbush Downgrades Chinook Therapeutics to Neutral From Outperform as Sale to Novartis Draws Closer; Keeps $42 Price Target
TG Therapeutics Upgraded at Goldman Sachs After Selloff
Analysts' Opinions Are Mixed on These Healthcare Stocks: Novartis AG (Six Swiss: CH:NOVN), CompuGroup Medical (GB:0MSD) and GlaxoSmithKline (GB:GSK)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevation Oncology (ELEV), Novartis AG (Six Swiss: CH:NOVN) and VBI Vaccines (VBIV)